CYP1B1 can metabolize AA into cardiotoxic metabolites exemplified as mid-chain hydroxyeicosatetraenoic acid (HETE), and 20-HETE is involved in the pathogenesis of cardiac hypertrophy and the consequent cardiac remodeling [36, 37]. Here, CYP1B1 is linked to cardiac hypertrophy.